PDCD1 and melanoma: The inhibition of PI3K, when combined with anti-PD-1 in syngeneic model of PTEN deficient melanoma resulted in an increased efficacy of immunotherapy, associated with an increase of CD8 T cells infiltration and efficient tumor regression (111).